Clinical Trials Logo

Filter by:
NCT ID: NCT05648799 Completed - Pharmacokinetics Clinical Trials

Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19

Start date: March 17, 2022
Phase: N/A
Study type: Interventional

Pharmacokinetics, safety and efficacy study of GP30341, 200 mg capsules (GEROPHARM LLC, Russia) in healthy volunteers and patients with novel coronavirus infection 2019 (COVID-19) with a high risk of adverse outcome

NCT ID: NCT05642845 Completed - Bioequivalence Clinical Trials

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Start date: November 19, 2022
Phase: Phase 1
Study type: Interventional

This is an open-labeled, randomized, two period, single-center, crossover, full replicative, comparative study, where each participant will be randomly assigned to the reference (Liprimar®, 40 mg film-coated tablets) or the test (Atorvastatin, 40 mg film-coated tablets) formulation in each period of study (sequences Test-Reference (TR) or Reference-Test (RT)), in order to evaluate if both formulations are bioequivalent.

NCT ID: NCT05641636 Completed - Clinical trials for Childhood Cancer Survivors

Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors

Start date: November 11, 2019
Phase:
Study type: Observational

The purpose of research is to study to adverse cardiovascular disorder and risks factors in childhood cranial and craniospinal tumors survivors. In this research the investigators investigate cardiological instrumental diagnostic, such as electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan for the prediction of cardiovascular complications after cranial and craniospinal radiotherapy and chemotherapy.

NCT ID: NCT05628116 Completed - Healthy Volunteers Clinical Trials

Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.

Start date: September 28, 2022
Phase: Phase 1
Study type: Interventional

A double-blind, randomized, placebo-controlled, Phase I clinical study of the safety, tolerability and pharmacokinetics (PK) of ascending doses of XC243 after single and multiple oral administration in healthy volunteers. It's planned to include sequentially 2 cohorts of 7 volunteers who will receive a single dose of XC243 (50 mg and 100 mg) or placebo (cohort ratio 5:2), 1 cohort of 14 volunteers who will receive a single dose of XC243 200 mg or placebo first on an empty stomach, and after the washing period after eating (cohort ratio 12:2) and 1 cohort of 10 volunteers who will receive XC243 200 mg or placebo on an empty stomach during 14 days (cohort ratio 8:2).

NCT ID: NCT05623761 Completed - Gingivitis Clinical Trials

Toothpastes With Thermal Water for Oral Health

Start date: November 1, 2022
Phase: Phase 4
Study type: Interventional

The aim of the study is to compare the effect of toothpastes containing thermal water of Castera-Verduzan with 1450 ppm fluoride and without fluorinated derivatives on oral hygiene, gingivitis, and dentin hypersensitivity in young adults.

NCT ID: NCT05605938 Completed - Clinical trials for Anxiety Disorder of Childhood

Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety Disorders

Start date: July 28, 2010
Phase: Phase 4
Study type: Interventional

Purpose of the study: • evaluate the efficacy and safety of Tenoten for children in children with anxiety disorders.

NCT ID: NCT05601167 Completed - COVID-19 Clinical Trials

Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population

Start date: February 17, 2021
Phase: Phase 3
Study type: Interventional

This is open-labe randomized multicenter comparative Phase III study conducted in 11 medical facilities. The objective of the study is to evaluate efficacy and safety of the drug JTBC00201, tablets in the setting of pathogenetic and symptomatic therapy as compared to standard therapy in outpatients with COVID-19.

NCT ID: NCT05595824 Completed - COVID-19 Clinical Trials

Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

This is open-labe randomized multicenter comparative Phase III study conducted in 12 medical facilities. The objective of the study is to evaluate efficacy and safety of the drug JCBC00101, capsules in the setting of pathogenetic and symptomatic therapy as compared to standard therapy in outpatients with COVID-19.

NCT ID: NCT05590598 Completed - Clinical trials for Seasonal Allergic Rhinitis

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

Start date: February 13, 2023
Phase: Phase 3
Study type: Interventional

Prospective, multicenter, open, randomized, parallel, clinical study for assessment of comparative efficacy and safety of Azelastine +Mometasone Sandoz (main group) and Momat Rino Advance (control group) administered as a monotherapy to patients with seasonal allergic rhinitis (SAR).

NCT ID: NCT05589558 Completed - Prostate Cancer Clinical Trials

Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to compare clinically significant prostate cancer detection rate by the 4 biopsy methods: TRUS-guided, cognitive, fusion and transperineal template mapping biopsy. It is recommended to combine MRI-guided biopsy with systematic (TRUS-guided or transperineal template mapping biopsy) biopsy for high yield of prostate cancer diagnosis. Nevertheless, it remains unclear which biopsy combination is more precise for prostate cancer detection.